Crinetics Pharmaceuticals Inc (CRNX)
56.86
+0.17
(+0.30%)
USD |
NASDAQ |
Nov 04, 13:15
Crinetics Pharmaceuticals Debt to Equity Ratio: 0.00 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2021
--
Maximum
Dec 2021
--
Average
--
Median
Dec 2021
Debt to Equity Ratio Benchmarks
| PTC Therapeutics Inc | -0.2906 |
| Zevra Therapeutics Inc | 1.796 |
| Clearside Biomedical Inc | 0.00 |
| Biomea Fusion Inc | -- |
| NovaBay Pharmaceuticals Inc | -1.128 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 935.54M |
| Total Liabilities (Quarterly) | 104.77M |
| Shareholders Equity (Quarterly) | 830.76M |
| Current Ratio | 16.09 |